Cho Young-Hye, Lee Youngin, Choi Jung In, Lee Sae Rom, Lee Sang Yeoup
Department of Family Medicine, Pusan National University School of Medicine, Yangsan 50612, South Korea.
Department of Family Medicine, Pusan National University Yangsan Hospital, Yangsan 50612, South Korea.
World J Clin Cases. 2023 Jun 26;11(18):4241-4250. doi: 10.12998/wjcc.v11.i18.4241.
Metabolic and bariatric surgery (MBS) is an effective treatment for patients with morbid obesity and its comorbidities. However, many patients experience weight regain (WR) after achieving their nadir weight. Establishing the definition of WR is challenging as postoperative WR has various definitions. Risk factors for WR after MBS include anatomical, racial, hormonal, metabolic, behavioral, and psychological factors, and evaluating such factors preoperatively is necessary. Long-term regular follow-up and timely treatment by a multidisciplinary team are important because WR after surgery is multi-factorial. Although lifestyle interventions that focus on appropriate dietary education, physical activity education or interventions, and behavioral psychological interventions are suggested, more well-designed studies are needed because studies evaluating intervention methods and the effectiveness of WR prevention are lacking. Anti-obesity drugs can be used to prevent and manage patients with WR after MBS; however, more research is needed to determine the timing, duration, and type of anti-obesity drugs used to prevent WR.
代谢与减重手术(MBS)是治疗病态肥胖及其合并症患者的有效方法。然而,许多患者在达到最低体重后会出现体重反弹(WR)。由于术后体重反弹有多种定义,因此确定体重反弹的定义具有挑战性。代谢与减重手术后体重反弹的风险因素包括解剖学、种族、激素、代谢、行为和心理因素,术前评估这些因素很有必要。由于术后体重反弹是多因素的,长期定期随访和多学科团队的及时治疗很重要。尽管建议进行以适当饮食教育、体育活动教育或干预以及行为心理干预为重点的生活方式干预,但由于缺乏评估干预方法和体重反弹预防效果的研究,因此需要更多设计良好的研究。抗肥胖药物可用于预防和管理代谢与减重手术后体重反弹的患者;然而,需要更多研究来确定用于预防体重反弹的抗肥胖药物的使用时机、持续时间和类型。